Horizon Technology Finance (HRZN)
(Delayed Data from NSDQ)
$11.01 USD
-0.05 (-0.45%)
Updated Sep 10, 2024 04:00 PM ET
4-Sell of 5 4
B Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
HRZN 11.01 -0.05(-0.45%)
Will HRZN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for HRZN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HRZN
New Strong Sell Stocks for August 8th
Horizon Technology Finance (HRZN) Q2 Earnings Surpass Estimates
HRZN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Saratoga Investment (SAR) Surpasses Q1 Earnings and Revenue Estimates
Horizon Technology Finance (HRZN) Gains As Market Dips: What You Should Know
Horizon Technology Finance (HRZN) Lags Q4 Earnings and Revenue Estimates
Other News for HRZN
Vesta Healthcare Raises $65 Million in Financing to Propel Growth
Horizon Technology finance provides $35M venture loan facility to Vesta Healthcare
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Vesta Healthcare
Stocks Going Ex Dividend In September 2024
2 BDCs That Improved And 2 That Got Worse After Q2 Earnings